Drugs / G-CSF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01969890 | Oct 2013 → May 2018 | acute myocardial infarction, left ventricular failure | Heart Care Foundation | Terminated | Missed primary Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01969890 ↗ |
| Modality | Protein / enzyme biologic | “G-CSF is a hematopoietic cytokine produced by monocytes, fibroblasts and endothelial cells.” NCT01969890 ↗ |
| Route | Subcutaneous | “5 microg/kg subcutaneous every 12 hours for 6 days” NCT01969890 ↗ |